Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of CJ-12420 in patients with gastric ulcer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer

Drugs mentioned

• CJ-12420

Snippet

Sponsor: HK inno.N Corporation | Conditions: Gastric Ulcer | Phase 3 | Status: COMPLETED